[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2622 followers Created: 2025-07-10 11:34:39 UTC $BIIB, STOK Stoke Therapeutics and Biogen will present data on Zorevunersen, an investigational medicine for Dravet syndrome, at the EPNS Congress. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$biib](/topic/$biib) [biogen inc](/topic/biogen-inc) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1943272651973390769)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2622 followers
Created: 2025-07-10 11:34:39 UTC
$BIIB, STOK Stoke Therapeutics and Biogen will present data on Zorevunersen, an investigational medicine for Dravet syndrome, at the EPNS Congress.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info $biib biogen inc stocks healthcare
/post/tweet::1943272651973390769